EACH Cardiovascular Health Summit 2025: Innovative and Powerful
Victoria Tzouma, International Health Policy Lead for General Medicine (CVD and Bone) and Obesity at Amgen, posted on LinkedIn:
“In anticipation of the EU Cardiovascular Health Plan being published tomorrow Safe Hearts Plan, I wanted to share how energised I felt last week leaving the EACH Cardiovascular Health Summit 2025 in Brussels.
It was a powerful moment to bring together policymakers, clinicians, patients, researchers and industry around what it will take to reduce Europe’s cardiovascular burden and, crucially, to move from ambition to implementation. Commissioner Olivér Várhelyi underlined both the opportunity of this EU plan and the importance of robust, long-term funding to make it real.
I was especially proud to see the EFPIA high-level panel reinforce a clear message: Member States will need sustained EU support to deliver impact, and screening/health checks must be part of the solution, particularly if we want to tackle inequalities within and across countries. One standout example was the population-wide cardiovascular screening programme implemented in Greece in 2025, showing what’s possible when early detection is delivered at scale. Thank you to the Alternate Minister of Health of Greece Eirini Agapidaki for sharing such valuable insights.
My sincere thanks as well to the rest of our panelists: Prof. Robert Gil for his perspectives on strengthening cardiology care in Poland; Ewa Piasecka Health Attaché at the Permanent Representation of Poland to the EU, for sharing experiences from the Polish national CVH plan; Arlene Wilkie from Stroke Alliance For Europe (SAFE) for keeping the patient experience front and centre and reinforcing the continued focus needed on stroke; Jesús Ponce highlighting the imperative to address inequities across the European landscape; and Borjana Pervan from World Heart Federation for her excellent moderation.
A big thank you to the European Alliance for Cardiovascular Health (EACH) and all partner organisations who made the summit possible. It was also great to connect with EFPIA – European Federation of Pharmaceutical Industries and Associations and Amgen colleagues in Brussels and celebrate how far we have come, while keeping focus on what comes next: delivery, equity, and investment.
Let’s make sure the hashtag#SafeHeartsPlan is matched with the resources needed to save lives.”
Get the latest updates abut hemostasis and thrombosis on Hemostasis Today.
-
Sep 20, 2026, 23:38Neil Blumberg: Group O Red Cells and Group AB Plasma Are Not Truly “Universal Donors”
-
Sep 20, 2026, 16:42Kate Grushetzkaya: The Essential Flow Cytometry Checklist – 6 Steps to Better Data
-
Sep 20, 2026, 16:32New Episode of The Hematologist Podcast – ASH
-
Sep 20, 2026, 16:26Thomas Schinecker: A New Era for Health Innovation – Inside the Roche Genentech Innovation Center
-
Sep 20, 2026, 16:19Astha Srivastava: The Missing Megakaryocytes in Amegakaryocytic Thrombocytopenia
-
Sep 20, 2026, 16:19Heghine Khachatryan: An Elegant Example of Precision Thrombolysis – Targeting the Scaffold of Microvascular Thrombosis
-
Sep 20, 2026, 16:01Mohamed Ismail: Managing Extensive Iliofemoral and Inferior Vena Cava DVT
-
Sep 20, 2026, 15:58Can αIIbβ3 Receptor Play a Role in Platelet Production – Glanzmann’s Research Foundation
-
Sep 20, 2026, 15:46Alexsander Santiago: Evaluating Clinical Harm from Missing versus Overdiagnosing HIT